The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
907-917
Author(s):
An Wouters, Carolien Boeckx, Jan B. Vermorken, Danielle Van den Weyngaert, Marc Peeters and Filip Lardon
Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
634-664
Author(s):
Andrey Voronkov and Stefan Krauss
Regulation and Function of DNA and Histone Methylations
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
719-733
Author(s):
Karin Johanna Ferrari and Diego Pasini
microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
745-764
Author(s):
Francesca De Santa, Ilaria Iosue, Alberto Del Rio and Francesco Fazi
Genistein Inhibits Cell Growth and Induces Apoptosis Through Up-regulation of miR-34a in Pancreatic Cancer Cells
Journal:
Current Drug Targets
Volume:
13
Page:
1750-1756
Author(s):
Jun Xia, Qiaoling Duan, Aamir Ahmad, Bin Bao, Sanjeev Banerjee, Ying Shi, Jia Ma, Jian Geng, Zhiwen Chen, KM Wahidur Rahman, Lucio Miele, Fazlul H Sarkar and Zhiwei Wang
Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
20-35
Author(s):
Julia Hobaus, Ursula Thiem, Doris M. Hummel and Eniko Kallay
Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
107-117
Author(s):
Stefan Pilz, Katharina Kienreich, Andreas Tomaschitz, Eberhard Ritz, Elisabeth Lerchbaum, Barbara Obermayer-Pietsch, Veronika Matzi, Joerg Lindenmann, Winfried Marz, Sara Gandini and Jacqueline M. Dekker
The Anti-cancer Actions of Vitamin D
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
126-139
Author(s):
Kun-Chun Chiang and Tai C. Chen
Inhibition of Cdc42-Interacting Protein 4 (CIP4) Impairs Osteosarcoma Tumor Progression
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
48-56
Author(s):
Nadezhda V. Koshkina, Ge Yang and Eugenie S. Kleinerman
Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
418-429
Author(s):
Custer C. Deocaris, Wen-Jing Lu, Sunil C. Kaul and Renu Wadhwa